Featured Research

from universities, journals, and other organizations

Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats

Date:
February 9, 1999
Source:
Kansas State University
Summary:
For some people, a string of beads is a fashion statement. For your dog or cat, they may be the difference between life or death. When surgery can't be performed or isn't enough to remove cancerous tumors, veterinarians at Kansas State University's College of Veterinary Medicine are using a new, implantable radiation treatment option. According to Dr. Ruthanne Chun, assistant professor of clinical sciences at K-State, brachytherapy is for dogs or cats that have certain tumors that aren't likely to spread to other parts of their body.

MANHATTAN -- For some people, a string of beads is a fashion statement. For your dog or cat, they may be the difference between life or death.

When surgery can't be performed or isn't enough to remove cancerous tumors, veterinarians at Kansas State University's College of Veterinary Medicine are using a new, implantable radiation treatment option. According to Dr. Ruthanne Chun, assistant professor of clinical sciences at K-State, brachytherapy is for dogs or cats that have certain tumors that aren't likely to spread to other parts of their body.

"Brachytherapy is something we've tried do more and more of here," Chun said. "There are maybe two or three other veterinary colleges that do it, so we are really riding the edge of that wave in being able to offer this service."

After as much of the tumor as possible is removed, a hollow, sterile plastic tube called an "after-loading tube" is sutured into the tumor bed. After the wound is closed, Chun said the radioactive beads are "essentially strung together on a plastic wire" and "fed" into the after-loading tubes. Once clamped in place, they begin to emit a set amount of radiation into the tumor bed.

"We know from past experience how much of a dose, how much radiation, a tumor needs to be effectively treated," Chun said. "We can calculate roughly how much radiation per day the tumor bed is receiving. After it has gotten its set dose, we sedate the animals, remove the tubes and the beads and they're done with their therapy."

Because the beads provide a continuous, low level dose of radiation, animals must be kept in isolation. Chun said owners are not allowed to visit their pets while they are receiving brachytherapy. The pets may still be allowed to go outside but must be kept away from other animals. They must also be handled only by veterinarians licensed to work with radioactive substances.

Chun said the treatment is, in some ways "much nicer" than conventional forms of radiation therapy. Animals do not have to go under anesthesia multiple times and the duration of the therapy is much shorter than with conventional or external beam radiation therapy.

"For conventional radiation therapy where you use an external beam unit, the animal has to lie still for the radiation therapy; this requires daily anesthesia anywhere from 10 to 15, or 20 times -- depending on what type of tumor it is," Chun said. "And the costs really add up when you have to anesthetize the animal each time and allow time for recovery. It's much harder on the animal than doing the implant therapy."

Chun said not all tumors can receive the implant, but that it is a good treatment option for a lot of different tumors.

"It seems to be as successful as more conventional forms of therapy," Chun said. "But we need two or three years from now before we can say our dogs have survived as long as, if not longer than, dogs treated with other forms of radiation."


Story Source:

The above story is based on materials provided by Kansas State University. Note: Materials may be edited for content and length.


Cite This Page:

Kansas State University. "Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats." ScienceDaily. ScienceDaily, 9 February 1999. <www.sciencedaily.com/releases/1999/02/990209072122.htm>.
Kansas State University. (1999, February 9). Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1999/02/990209072122.htm
Kansas State University. "Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats." ScienceDaily. www.sciencedaily.com/releases/1999/02/990209072122.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins